6Creasman WT,Kohler MF.Is lymph vascular space involvement and independent prognostic factor in early cervical cancer|J].Gynecd Oncol,2004,92(2):525-529.
7J Monk BJ,Cha DS,Walker,et al.Extent of disease as a flindication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage Ⅰ B and Ⅱ A cervical carcinoma[J].Gynecol Oncol,1994,54(1):4-9.
5Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol, 1974, 44:265-272.
6Plentl AA, Friedman EA. Lymphatic system of the female genitalia: the morphologic basis of oncologic diagnosis and therapy. Major Probl Obstet Gynecol, 1971, 2 : 1-223.
7Benedetti-Panici P, Maneschi F, D'Andrea G, et al. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Cancer, 2000, 88:2267-2274.
8Suprasert P, Srisomboon J, Kasamatsu T, et al. Radical hysterectomy for Ⅱ B cervical cancer: a review. Int J Gynecol Cancer, 2005, 15:995-1001.
9Malur S, Krause N, Kohler C, et al. Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol, 2001, 80 : 254-257.
10Fuller AF Jr, Elliott N, Koslotff C, et al. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage Ⅰ B and Ⅱ A carcinoma of the cervix. Gynecol Oncol, 1989,33:34-39.
9Monk B J, Wang J, Im S, et al. Rethinking the use of radia- tion and chemotherapy after radical hysterectomy:a clinical- pathologic analysis of a Gynecologic Oncology Group/ Southwest Oncology Group/Radiation Therapy Oncology Group trial[ J ]. Gynecol Oncol, 2005,96 (3) :721.
10Sakuragi N, Satoh C, Takeda N, et al. Incidence and distri- bution pattern of pelvic and paraaortic lymph node metasta- sis in patients with Stages I B, II A., and ]I B cervical car- cinoma treated with radical hys-terectomy [ J ]. Cancer, 1999,85 ( 7 ) : 1547.
